External Quality Controls

SARS Complete Panel

Respiratory Viral Panel

STI Panel

HPV Panel

Gastrointestinal Panel

ONBOARDx Kits

Proficiency Testing

Genital Ulcer Panel

Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions

“Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™”

Gaetano Natale, Chief Commercial Officer.

The Microbix Difference

Our Quality Commitment

By choosing Microbix Biosystems Inc., you are aligning with a partner certified to the latest ISO standards and dedicated to delivering products that truly set the benchmark for quality in the industry.

Decades of Expertise

With over three decades of experience in the global diagnostics industry, Microbix has established a reputation as a leading infectious disease diagnostic manufacturer.

Widespread Customer Acceptance

Microbix’s products have consistently earned widespread recognition and trust from customers due to their superior reliability.

Download Our Full Product Catalogue

DOWNLOAD PRODUCT CATALOGUE

News & Insights from Our Diagnostics Experts

Microbix’s Corporate Presentation

Profitable growth from supporting next generation Diagnostics. Click below to download..

May 5, 2025
Microbix’s Clot-Buster Drug Project Advances

Microbix announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed an agreement with a leading international contract development and manufacturing organization (“CDMO”) for production of the formulated and packaged drug (i.e., “Drug Product”) of Kinlytic® urokinase (“Kinlytic”), a biologic drug for dissolving blood clots.

May 5, 2025
Microbix Presenting at the 2025 Bloom Burton Conference

announces it will be attending and presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on Monday and Tuesday, May 5 & 6, 2025.

May 1, 2025